Gene therapy--the future is here: a guide to the practicing urologist (Q40866188)

24 September 2017

1 reference

title

Gene therapy--the future is here: a guide to the practicing urologist (English)

1 reference

24 September 2017

0 references

Naitoh J

1

1 reference

PubMed ID

9510338

24 September 2017

Belldegrun A

series ordinal

2

1 reference

PubMed ID

9510338

24 September 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

24 September 2017

1 reference

24 September 2017

51

1 reference

24 September 2017

3

1 reference

24 September 2017

367-380

1 reference

Adenoviral-mediated gene transfer of human surfactant protein B to respiratory epithelial cells

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

In vivo cytokine gene transfer by gene gun reduces tumor growth in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Systemic gene expression after intravenous DNA delivery into adult mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Improved cationic lipid formulations for in vivo gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Preclinical Pharmacokinetics, Manufacturing, and Safety Studies Supporting a Multicenter Cancer Gene Therapy Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Gene Transfer In Vivo with DNA–Liposome Complexes: Safety and Acute Toxicity in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Cancer Gene Therapy Using Plasmid DNA: Safety Evaluation in Rodents and Non-Human Primates

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Development of gene therapy for prostate cancer using a novel promoter of prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Re: Transrectal ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Molecular genetics of tumor suppressor genes in prostate carcinoma: the challenge and the promise ahead

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Expression of ras oncogene p21 in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Chromosomal defects in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Induction of human cytotoxic T lymphocytes specific for prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Rb gene therapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Adenovirus-mediated suicide gene therapy for experimental bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

1 reference

7 January 2021

Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Screening for von Hippel-Lindau disease by DNA polymorphism analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Identification of the von Hippel-Lindau disease tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Specific genetic change in tumors associated with von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Cytogenetic findings in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Localized renal-cell carcinoma: detection of abnormal cells in peritumoral tissue. A cytophotometry and immunocytochemistry study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900624-9

7 January 2021

10.1016/S0090-4295(97)00624-9

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9510338